A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis.
Margaret H Y MaN DefranouxW LiE H SassoF IbrahimD L ScottA P CopePublished in: Arthritis research & therapy (2020)
This study demonstrated that the MBDA score and its biomarkers IL-6, leptin, SAA and CRP differentiated between small differences in disease activity (i.e. between low disease activity and remission states). They were also predictors of remission over 1 year.